The Liberta RC™ DBS system features the smallest DBS IPG on the market(3***) designed for patient comfort(1*) and has a charging frequency of 10 times per year(2**). Hear from people with the Liberta RC™ DBS System on what their experience has been like.
Learn more about the Liberta RC™ DBS System here: abbo.tt/learnmoreaboutthelibertarcdbssystem
Subscribe to our channel today: bit.ly/3NrkbUp
Connect with us on Facebook: bit.ly/3a32X0O
Follow us on LinkedIn: abbo.tt/NMLinkedIn
#LibertaRC #PatientTestimonials #DeepBrainStimulation
Important Safety Information: bit.ly/AbbottImportantSafetyInformation
*Patient comfort resulting from reduced features that could lead to discomfort (i.e. sharp edges) and reduced size compared to on-market IPGs.
**Upon implant of the Liberta RC™ DBS System, 37 days of therapy when programmed with standard (nominal) stimulation settings as described in device instructions for use.
***US market only. Based off comparison to volume of the following smallest IPG offerings from US DBS manufacturers: Abbott Liberta RC™ DBS System: 13.6 cc, Boston Scientificǂ Vercise Genusǂ R16: 20.1 cc and Medtronicǂ Perceptǂ RC: 13.77 cc.
1. Abbott. Gemini Validation Bench Testing Report. 2021.
2. Abbott. Liberta RC™ Implantable Pulse Generator Clinician's Manual. Plano, TX. 2024.
3. Abbott. Liberta RC™ DBS System Size Comparison Claims Memo. 2024.
Note: This testimonial relays an account of an individual’s response to the treatment. This patient’s account is genuine, typical, and documented. However, it does not provide any indication, guide, warranty or guarantee as to the response other persons may have to the treatment. Responses to the treatment discussed can and do vary and are specific to the individual patient.
These materials are not intended to replace your doctor’s advice or information. For any questions or concerns you may have regarding the medical procedures, devices and/or your personal health, please discuss these with your physician.
This video is not intended for reposting or redistribution on non-Abbott websites or other external channels without explicit, written consent.
Risk Information: There is no cure for Parkinson’s disease (PD) and essential tremor (ET), but there are options available to treat symptoms. The first-line therapy is medication. Surgical treatments are also available. It’s important to discuss with your doctor what’s right for you along with the risks and side effects of each option, such as motor fluctuations or permanent neurological impairment. As with any surgery or therapy, DBS has risks and complications. Loss of coordination is a potential side effect of DBS therapy. Patients should exercise reasonable caution when participating in activities requiring coordination, including those that were done before receiving therapy (for example, swimming). Patients should also exercise reasonable caution when bathing. New onset or worsening depression, which may be temporary or permanent, is a risk that has been reported with DBS therapy. Suicidal ideation, suicide attempts, and suicide are events that have also been reported. Most side effects of DBS surgery are temporary and correct themselves over time. Some people may experience lasting, stroke-like symptoms, such as weakness, numbness, problems with vision or slurred speech. In the event that the side effects are intolerable, or you are not satisfied with the therapy, the DBS system can be turned off or surgically removed. Risks of brain surgery include serious complications such as coma, bleeding inside the brain, paralysis, seizures and infection. Some of these may be fatal.